Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)14

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)9

Views

Views
May 20245
June 20240
July 20240
August 20240
September 20243
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Canada1
 

Top cities views

Views
Chicago4